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phetic Hadith. It includes remedy recipes, by which the
Prophet, peace be upon him, was cured or he called
people to be cured by. Furthermore, it includes recom-
mendations relevant to human health in the conditions of
life, including eating, drinking, housing, and marriage. It
comprehends legislations related to medication, medicine
in practicing the profession, and the guarantee of the
patient in the perspective of Islamic Law. Ibn Al Qayyim,
may Allah be merciful with him, in his book Zad Al
Ma’ad Fe Haday Khair Al Abad, said: “The medicine of
the Messenger, peace be upon him, is not similar to the
medicine of physicians. The medicine of the Prophet,
peace be upon him, is certain, categorical, and godly
medicine; issued by the Revelation, Prophethood niche,
and sagacity; while the medicine of others is inductive,
assumptive, and experimental.”
In KSA alone, 3.8 million cases of diabetes were recorded,
thus warranting increased global health concern. Scientific
evidence has accorded the claim of several plants and
honey listed in prophetic medicine, which improve gly-
caemic control in diabetes mellitus. In addition to their
hypoglycaemic effect, studies indicate that extracts from
those plants and honey ameliorate other associated
metabolic derangements. In this review, we present several
of the latest findings linking the bioefficacy of these plants
and honey with the pathogenesis of diabetes and insulin
secretion in diabetes mellitus subjects.
Keywords: Alternative medicine; Diabetes; Natural products;
Phytochemicals; Prophetic medicine
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glucose; GI, glycaemic index; GII, insulinaemic response; GLP,
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density lipoproteinsIntroduction
Diabetes mellitus is among the most important clinical
risk factors involved in several disorders, including athero-
sclerosis, neuropathy, nephropathy, retinopathy and stroke.1
Avicenna, a renowned physician of the golden ages,
described diabetes in his book ‘The Canon of Medicine’
and mentioned gangrene among its complications.2,3
Currently, it has been reported that approximately 387
million people live with diabetes globally, and it is
projected to double by 2030.4 In KSA alone, 3.8 million
cases of diabetes were recorded in 2015.5 Owing to this,
global healthcare expenditures on the management of type
2 diabetes mellitus alone are anticipated to skyrocket from
US $376 billion in 2010 to US $490 billion in 2030.6 Thus,
diabetes mellitus warrants the current increasing global
health concern.
It is well accepted that insulin resistance plays a primary
role in diabetes pathogenesis and that failure of pancreatic
b-cells to secrete insulin is instrumental in the progression to
hyperglycaemia. Pancreatic b-cells secrete insulin to
regulate blood glucose homeostasis. The dysfunction and
injury of these cells contribute to the pathogenesis of type 1
and type 2 diabetes.7 Insulin secretion is subject to control
by nutrients and by hormonal, neural, and
pharmacological factors. Among these, glucose is by far
the most important regulator of the machinery of insulin
secretion.8 In fact, chronic hyperglycaemia has been
shown to be involved in b-cell dysfunction, a phenomenon
described as glucotoxicity.9
Some of the current anti-diabetic drugs in use act mainly
by inhibiting carbohydrate digestion and absorption. For
example, Acarbose (BAY g 5421) was the first a-glucosidase
inhibitor available for diabetes treatment. This drug in-
hibits the activities of a-amylase, sucrase and maltase,
whereas voglibose is a newer a-glucosidase inhibitor of
bacterial origin that inhibits the activities of isomaltase,
sucrase and maltase. Although, the majority of these drugs
is efficient in maintaining postprandial blood glucose levels
in many patients, their administration is often associated
with major gastrointestinal adverse effects. The looming
concerns over possible health complications that arise as
side effects of commercially available antihyperglycaemic
compounds are partly responsible for the prevalence of
nonadherence to medication that occurs in diabetic pa-
tients. This has become a driving force in the current mo-
mentum for seeking alternative therapies with less severe
side effects. In this sense, herbal compounds appear to offermilder means of managing metabolic disorders. Therefore,
the use of phytotherapy in the management of diabetes is
well documented in traditional medicine systems, such as
Chinese, Indian ayurveda and Arabic unani. A myriad of
studies has substantiated the beneficial effects of medicinal
herbs for controlling glycaemic status.10e13 Among the
phytotherapeutics are those listed in Islamic scholarly
prophetic medicine, such as Nigella sativa, Cymbopogon
spp., and Olea europaea.
In this regard, this review aims to delineate the current
research concerning the hypoglycaemic efficacy of several
phytotherapeutic plants described in prophetic medicine,
otherwise known as Tibb Al-Nabawi.N. sativa
N. sativa (black cumin) is an important medicinal herb
that finds application in a wide range of diseases. Its medical
importance is documented in prophetic traditions. It has
been reported on the authority of Aisha, may Allah be
pleased with her, who narrated that she heard the Prophet,
peace be upon him, saying, “This black cumin is healing for
all diseases except As-Sam.” Aisha, may Allah be pleased
with her, asked ‘What is As-Sam?’ He (the Prophet peace be
upon him) replied ‘Death’.14 Similarly Abu Huraira, may
Allah be pleased with him, narrated, “I heard the Prophet,
peace be upon him, saying, “There is healing in black
cumin for all diseases except death.”14
Scientifically, the biological activities of N. sativa are well
studied.15e20 Among the reported bioactive compounds of
this plant are linoleic acid, melanthin, nigilline,
thymoquinone, nigellone (dithymoquinone), damascenine,
and tannins.21,22 In particular, thymoquinone has been
shown to induce mitochondria-mediated apoptosis,23 anti-
diabetic properties,24 and antioxidative stress.25 The
hypoglycaemic effect of N. sativa has been reported in
several studies.26,27 One study illustrated that N. sativa
significantly lowered glycated haemoglobin (HbA1c),
fasting blood glucose (FBG) and postprandial blood
glucose (PPBG) levels after 8 weeks. In fact, upon
administering the N. sativa extract, the FBG was reported
to be reduced by approximately 13% compared to the
control (Table 1). In contrast, Adnyana et al.28 reported a
reduction in FBG of approximately 8% after 90 days of
administering N. sativa (Table 1).
Likewise, treatment with N. sativa extract at a concen-
tration of 5 mg/kg bw significantly reduced the FBG level
when compared to the control, partially recovered hepatic
glycogen content and protected a large amount of pancreatic
islet cells.29 Furthermore, studies have shown that
supplementation with either N. sativa or its essential oils
hold insulinotropic potential mediated by extra-pancreatic
action.17 This was in accordance with Kanter,30 who
observed that administering N. sativa or its bioactive
compound thymoquinone at a dose of 400 and 50 mg/kg
body weight/day, respectively, caused a marked decrease in
glucose and increased serum insulin concentrations in
streptozotocin-induced diabetic rats.
Similarly, in vitro studies have shown that N. sativa incurs
increased insulin secretion in isolated rat pancreatic islets in
the presence of 8.3 mmol/L glucose.31 Additionally, it had
Figure 1: Isolated compounds from N. sativa seeds. Adopted from
Yuan et al.43 (a. 17-O-(b-D-glucopyranosyl)-4-O-methylnigellidine,
b. nigelanoid, c. nigellidine, d. 4-O-methylnigellidine, e. nigegla-
nine and f. 4-O-methylnigeglanine).
Table 1: Influence of N. sativa intervention on plasma glucose levels (adopted from Najmi et al.26, Adnyana et al.28).
A Parameters Before intervention
(Mean  SD)
After intervention
(Mean  SD)
FBG (Std) 144.2683  21.6042 135.6951  11.6414
FBG (NS) 165.5823  32.5772 144.3411  12.9111
B Group Plasma glucose
level (mg/dL)
0 60 90
Control 125.60  31.28 242.20  56.95 186.00  69.04
NS1 129.60  27.78 239.80  39.54 180.80  24.77
NS2 128.20  25.52 212.60  32.18 171.00  34.97
Management of diabetes mellitus 341been proposed that N. sativa has the ability to restore the
structural integrity of pancreatic islets in streptozotocin-
induced diabetic rats.30 This is in accordance with
histopathological and immunohistochemical studies that
revealed the morphological integrity of b-cells of pancreatic
islets recovered after treatment with N. sativa or its seed
oil.32,33 A recent randomized double-blind, placebo-
controlled trial demonstrated the efficacy of N. sativa oil on
glucose metabolism and lipid concentrations in patients with
type 2 diabetes.34
A previous study showed that the hypoglycaemic effect of
N. sativa is due to decreased oxidative stress and preservation
of pancreatic b-cell integrity,35 and most of N. sativa
antioxidant potency is associated with the presence of
thymoquinone.15 A previous study illustrated the
antioxidant effects of N. sativa to be due to the inhibition of
eicosanoid generation and membrane lipid peroxidation.36
In another study, it was demonstrated that N. sativa seed
ethanol extract (NSE) exhibits the remarkable ability to
concomitantly increase insulin secretion, induce
proliferation of pancreatic b-cells, and stimulate glucose
uptake in skeletal muscle and fat cells in vitro.37 Its oil
extract was shown to repair damaged pancreatic tissue
induced by diabetes.38 Additionally, supplementation with
N. sativa extract incurred insulin secretion, glucose
absorption and hepatic gluconeogenesis.39,40
It has been reported that cellular energy homeostasis in-
volves AMP-activated protein kinase (AMPK) as a major
enzyme.41 The AMPK pathway performs a primary function
in the regulation of glucose and lipid metabolism. Thus, the
activation of AMPK is thought to stimulate hepatic fatty
acid oxidation and ketogenesis.41 Furthermore, AMPK
activation inhibits cholesterol synthesis, lipogenesis, and
triglyceride synthesis; stimulates skeletal muscle fatty acid
oxidation and muscle glucose uptake; and modulates
insulin secretion by pancreatic b-cells.42 Recently, six rare
naturally occurring indazole-type alkaloids (Figure 1)
isolated from N. sativa seeds were shown to exhibit
antihyperglycaemic effects via AMPK activation in vitro.43
Of these isolated compounds, 17-O-(b-D-glucopyranosyl)-4-
O-methylnigellidine (Figure 1a) was described to increase
glucose consumption by liver hepatocytes (HepG2 cells)
through activation of AMP-activated protein kinase.43 In a
similar study, the in vivo anti-diabetic activity of N. sativa
was described to be mediated through the activation of the
AMPK pathway and increased muscle glucose transporter
‘Glut4’ content.32Cymbopogon citratus
C. citratus (lemon grass) is a well known medicinal herb in
tropical and subtropical countries, especially in Southeast
Asia.44 Cymbopogon essential oil is often used in
aromatherapy. Its importance to the Arab and Islamic
community has been documented for over a millennium. It
is narrated that Prophet Muhammad, peace be upon him,
said “. (It is not allowed to uproot its (the Holy city of
Makkah) thorny shrubs, hunt its game, pick up its lost
objects, except by announcing it, or to uproot its trees.)
And Al-‘Abbas, may Allah be pleased with him, said,
B.Y. Sheikh342‘Except the lemon grass, O Allah’s Messenger, as they use it
in their houses and graves.’ And the Prophet, peace be upon
him, said: Except lemongrass.”
Medically, the plant is known to contain bioactive com-
pounds, such as citral a, citral b, nerol geraniol, citronellal,
terpinolene, geranyl acetate, myrecene and terpinol methyl-
heptenone.22 The plant also contains reported
phytoconstituents, such as flavonoids and phenolic
compounds, which consist of luteolin, isoorientin 20-O-
rhamnoside, quercetin, kaempferol and apiginin.45 Studies
have indicated that C. citratus possesses various
pharmacological activities, such as anti-amoebic, anti-bac-
terial, anti-diarrheal, anti-filarial, anti-fungal and hypo-
glycaemic properties.46e48
The hypoglycaemic and hypolipidaemic effects of aqueous
extracts of C. citratus in experimental diabetic rats were
evaluated.49 The research evaluated blood samples from rats
for fasting plasma glucose (FPG), total cholesterol,
triglycerides, low-density lipoproteins (LDL-c), very low-
density lipoprotein (VLDL-c) and high-density lipoprotein
(HDL-c) assays through cardiac puncture under halothane
anaesthesia. The results obtained from their analysis indicated
that C. citratus treatment significantly and dose-dependently
lowered the FPG and lipid parameters while raising plasma
HDL-c levels.49 It has been proposed that the observed
hypoglycaemic activity associated with C. citratus extract
could be due to increased insulin synthesis and secretion
(hyperinsulinaemia) or increased peripheral glucose
utilization.49 In a similar study, Campos et al.50 showed that
C. citratus bioactive compounds (chlorogenic acid,
isoorientin and swertiajaponin) displayed 60% inhibition of
reactive oxidative species (ROS) production in human
umbilical vein endothelial cells (HUVECs) challenged with
high D-glucose. Additionally, the extract was able to inhibit
vasoconstriction induced by the thromboxane A2 receptor
agonist U46619, thus suggesting a NO-independent vasodi-
lator effect on blood vessels.50 These studies on C. citratus
hypoglycaemic bioactivity were found to be at variance with
that of Leite et al.51 in humans; they reported that tea made
from the dried leaves of C. citratus induced no glycaemic
changes in patients treated with the tea for 2 weeks. The
observed contrast between these studies could be attributed
to the fact that variations may occur in bioactive
compounds of different parts of the same plant and even in
the same parts found in different environments52 or due to
differences in plant materials used, dosage and duration of
drug exposure.49
Similarly, Bharti et al.53 evaluated the anti-diabetic activ-
ities of C. citratus essential oil obtained by steam distillation
of the leaf sheath in poloxamer-407-induced type 2 diabetic
Wister rats. GCMS analysis of the extracted essential oil
revealed the presence of 23 compounds, of which geranial
(42.4%), neral (29.8%), myrcene (8.9%) and geraniol (8.5%)
were the major compounds.53 Post-treatment analyses indi-
cated that diabetic rats presented significant amelioration of
glycaemia, insulinaemia, lipid dysmetabolism, accompanied
by increased GLP-1 content in caecum and a remarkable
reduction of oxidative markers.53 It has been documented
that GLP-1 plays a key role in insulin secretion, glucagon
and somatostatin inhibition, pancreatic b-cell mass develop-
ment, maintenance, and expansion.54 Furthermore, in silico
molecular HYBRID and FRED docking have shown thatC. citratus bioactive compounds, such as myrcenol, linalool,
a-elemol and b-eudesmol, showed significant interactions
with the proteins PPAR-g and DPP-IV, which are known
to be key anti-diabetic pathways.53 Aldose reductase is a
known rate-limiting enzyme in the hazardous polyol
pathway of glucose metabolism, which becomes active when
intracellular glucose levels are elevated. This enzyme reduces
glucose to sorbitol using NADPH as a co-factor; sorbitol is
then metabolized to fructose by sorbitol dehydrogenase that
uses NADþ as a cofactor. As in previous studies, molecular
docking was used to analyse the effect of essential phyto-
chemicals obtained from C. citratus on aldose reductase ac-
tivity.55 C. citratus essential bioactive compounds, such as
myrcene, citral, and geraniol, were used as ligands, while
aldose reductase was used as the receptor in the molecular
docking analysis. The docking analysis showed myrcene,
with a binding energy of 8.76 kcal/mol as the best
amongst citral and geraniol, which had binding energies
of 7.24 kcal/mol and 7.93 kcal/mol, respectively, for
inhibiting aldose reductase activity.55
a-Amaylase is an enzyme that catalyses the hydrolysis of
1,4-glucosidic linkage of complex carbohydrates, such as
starch, into simple sugars, namely maltose. Controlling
glucose production from complex carbohydrates is effective
for controlling diabetes. Thus, inhibition of a-amylase ac-
tivity is considered to be an important strategy in the man-
agement of diabetes. Jumepaeng et al.56 reported the
inhibition of a-amylase by essential oil extracted from
C. citratus. The study indicated that C. citratus essential oil
incurred an a-amylase inhibitory activity in the form of
IC50 of 6.97  0.12 mL/mL56Olive (Olea europaea)
The olive tree is a species of evergreen tree belonging to
the family Oleaceae and is native to the coastal areas of the
Mediterranean, Asia and Africa. Owing to their rich oil
contents, the olive fruits are of major agricultural importance
to the Mediterranean region. For several millennia, olive oil
has been used in food and cooking as well as in lighting,
sacrificial offerings, ointment, and anointment for priestly or
royal offices.57 Its significance is well established in Islamic
medicine. In the Holy Quran, Allah the almighty says:
“And a tree (olive) that springs forth from Mount Sinai,
that grows oil, and (it is a) relish for the eaters.”58
Similarly, it has been reported in prophetic tradition by
Omar bin Al-Khattab, may Allah be pleased with him,
who narrated that the Prophet, peace be upon him, said:
“Eat the oil and anoint yourself with it, for it comes from a
blessed tree.”59
A chemical analysis of olive revealed the presence of
several triglycerides; phenolic compounds, such as hydrox-
ytyrosol, tyrosol, caffeic acid, phydroxyphenylacetic acid
and homovanillic acid; as well as several flavonoid esters.60,61
In a recent study, high speed counter-current chromatog-
raphy (HSCCC) coupled with post-column on-line evalua-
tion was developed to screen for the bioactive compounds in
olive leaf extracts. The research revealed the presence of
oleuropein, ligstroside, hydroxytyrosol, tyrosol and luteolin-
7-O-b-D-glucoside.62 Studies have reported that the healing
power of olive oil comes from its high antioxidant activity
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addition to its biocompatibility and digestibility. Several
studies have reported the bioactivity of O. europaea,
including antioxidant,63 antimicrobial,64 antiulcerogenic,65
antinociceptive66 activities.
Recently, the significance of supplementation with olive
leaf extract (OLE) as an antioxidant in reducing metabolic
abnormalities in diabetic male albino rats was evaluated.67
Diabetic rats were administered OLE orally twice daily for
30 days. At the end of the experimental period, levels of
serum insulin and glucose in addition to lipid patterns,
such as total cholesterol (TC), triglycerides (TG), high
density lipoproteins (HDL), low density lipoproteins
(LDL), and very low density lipoproteins (VLDL), and
renal markers were determined. After OLE administration,
diabetic rats showed marked increases in levels of serum
insulin accompanied with marked declines in levels of
fasting blood glucose compared to controls.67 It has been
reported that oleuropein, a phenylethanoid compound
displayed, distinct hypoglycaemic effects at an
administrative dose of 16 mg/kg2.
Powdered mixtures of olive leaf with Juglans regia,
Urtica dioica, and Atriplex halimus were reported to
decrease glucose absorption from the intestine and lower
blood glucose levels in rats and diabetic subjects.68 Kadan
et al.2 has shown that exposing L6-GLUTmyc cells to 250
mg/mL of olive extract significantly decreased glucose
transporter 4 (GLUT4) translocation from 100% to 80%
in the basal state without insulin stimulation and from
150% to 105% in insulin-stimulated cells. The research
attributed the observed anti-diabetic effects of olive
extract to several mechanisms, including GLUT4
translocation. In an advanced study, supplementation of
rat diet with 10% olive oil induced improvement of
glucose tolerance and insulin secretion.69 Additionally,
histopathological study of the isolated pancreas of rats
supplemented with olive oil showed an increased
response of Langerhans islets to glucose stimulus by
strong oxidation of glucose, which resulted in increased
insulin secretion.69,70
Oleanic acid (oleanolic acid), a naturally occurring tri-
terpenoid commonly found in olive oil, has been described to
improve insulin response, preserve functionality, increase
survival of pancreatic b-cells, and protect against diabetes
complications.71 Oleanic acid is thought to directly modulate
enzymes connected to insulin biosynthesis, secretion, and
signalling. It interacts with important transduction
pathways by activation of the transcription factor Nrf2.71
Hence, it induces the expression of antioxidant enzymes
and phase II response genes, which block NF-kB and
repress the polyol pathway and hyperlipidaemia.71 As
mentioned earlier, carbohydrate digestion is facilitated by
enteric enzymes, such as a-glucosidase and a-amylase, in
small intestinal cells. Their inhibition permits better control
of postprandial hyperglycaemia. Studies have shown that
oleanic acid inhibits a-glucosidase in vitro in a dose-
dependent fashion.72e74 It has also been reported to inhibit
a-amylase.75 The anti-diabetic and antioxidant effects of
hydroxytyrosol and oleuropein from olive leaf extracts were
evaluated in alloxan-induced diabetic rats.76 Khlif et al.77
described the anti-diabetic property of a new methylated
oleanic acid isolated from olive stems. The isolatedcompound was also found to inhibit the activities of a-
amylase and lipase.77 A recent study has indicated that
diabetes causes a significant elevation in the level of hepatic
arylsulfatase B and a significant reduction of hepatic
catalase as an antioxidant enzyme. Supplementation of
olive oils returned catalase and arylsulfatase B activities to
normal levels, thus exerting hypoglycaemic activity.78Salvadora persica (Miswak)
The mustard tree, commonly called tooth brush tree or
‘Miswak’ in Arabic, belongs to the taxonomic family of
Salvadoraceae.79 The tree has a pleasant fragrance as well as
a warm and pungent taste; the tender branches have been
popularly used for centuries as a natural toothbrush,
particularly within the Arabian Peninsula as well as in the
wider Muslim world.80,81 Its usage is recorded in the
prophetic tradition by Abu Hurairah, may Allah be
pleased with him, who narrated that the Prophet, peace be
upon him, said: “Had I not thought it difficult for my
Ummah, I would have commanded them to use the
Miswak (tooth-stick) before every Salah (praying).”14,82 A
phyto-chemical analysis of S. persica revealed that the
plant contained specific amounts of salvadorine; salva-
dourea; terpenes; trimethylamine; gypsum; organic com-
pounds, such as pyrrolidine, pyrrole, and piperidine
derivatives; chlorides; sulphur; vitamin C; carbohydrates;
glycosides; large amounts of fluoride and silica; and trace
amounts of tannins, saponins, flavonoids and sterols.83,84
The anti-hyperglycaemic activity of S. persica in
streptozotocin-induced diabetic rats has been reported.85
The research showed that a hydro-alcoholic extract of the
S. persica significantly and dose-dependently reduced blood
glucose level.85 Previously, the stem decoction of S. persica
was shown to significantly lower glucose levels in rats, and
the reduction of glucose levels was shown to be due to
increased plasma insulin levels.86 Furthermore, the research
opined that most phytochemical compounds having
sulphur derivatives may incur hypoglycaemic efficacy.86
In another approach, different extracts obtained from
fungal strains isolated from Salvadora were evaluated for
anti-diabetic and hypolipidaemic activity in glucose-loaded
fasting and alloxan-induced diabetic Wister albino rats.87
In their research, glucose tolerance tests were used to
ascertain the blood glucose levels. They found that only
four extracts significantly reduced blood glucose levels,
namely unidentified fungus (aqueous), Aspergillus sp. JPY2
(methanol), Aspergillus sp. JPY1 (methanol) and Phoma sp.
(acetone).87 Furthermore, they observed that, in alloxan-
induced diabetic rats, the maximum reduction of blood
glucose levels was after 5 h in the acute treatment experiment
and on the 14th day in the subacute treatment at a dose of
250 mg/kg of body weight. In comparison to the standard
drug tolbutamide that reduced the blood glucose level up to
40% in long term treatment, the reduction in blood glucose
in the isolate extracts ranged from 11.3% to 28.04%.87 A
study published by Khan et al.88 induced diabetes in albino
Wistar rats by a single intraperitoneal injection of
streptozotocin (60 mg/kg). The researchers compared the
efficacy of Indian and Arabian S. persica root extracts by
administering it orally at 250 and 500 mg/kg doses to
Figure 2: Effect of Arabic origin (A) and Indian origin (B) aqueous extracts of Salvadora persica on hyperglycaemia. a, b, c are statistically
significant levels at P < 0.001 and P < 0.05 compared with the control group. Adopted from Khan et al.88
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described that arabic S. persica aqueous extracts at
500 mg/kg dose level possessed significant hypoglycaemic
and hypolipidaemic activities and regenerated pancreatic b-
cells in streptozotocin-treated diabetic rats.88Honey
Honey is considered one of nature’s valuable functional
and medicinal foods.89 In the Holy Quran, Allah the
almighty says: “And your Lord inspired to the bee, take
for yourself among the mountains, houses, and among the
trees and [in] that which they construct. Then, eat from all
the fruits and follow the ways of your Lord laid down [for
you]. There emerges from their bellies a drink, varying in
colours, in which there is healing for people. Indeed in that
is a sign for a people who give thought.”58 Abu Sa’eed al-
Khudree, may Allah be pleased with him, narrated, “A
man came to the Prophet, peace be upon him, and said, ‘My
brother has pain in his stomach,’ so the Messenger, peace be
upon him, said: ‘Give him honey to drink.’ The man came
back and said, ‘O Messenger of Allah! It only increased his
illness!’ So the Messenger, peace be upon him, said, ‘Give
him honey to drink.’ The man came back and said, ‘O
Messenger of Allah! It only increased his illness!’ The
Messenger of Allah, peace be upon him, said ‘Allah spoke
the truth and your brother’s belly has lied. Go and give him
honey to drink.’ He went and gave him honey and was
cured.”14,82
Honey is a natural food and a complex mixture of sugars,
in which fructose and glucose are the main constituents. It
has been shown to possess novel antioxidant90 and
antimicrobial91 properties. Due to the reduced secretion of
insulin in response to glucose in the blood, diabetes
patients are restricted to specific food types. The restriction
put on their diet deprives them of many elements in their
natural form. Thus, synthetic sweeteners, such as
aspartame, saccharin and other artificial and chemical
sweeteners that have no food value, are used to replace
sugar in their food and drinks. It has been proposed that
pure natural honeys in low doses could be recommended asa source of carbohydrates and even as a sweetening agent
in place of sucrose to human patients suffering from
diabetes mellitus.92 The effect of natural honey
supplementation on the blood glucose levels of alloxan-
induced diabetic rats has been reported.92 The research
noted that daily ingestion of honey for three weeks
effectively reduced blood glucose levels in rats with
alloxan-induced diabetes. However, the honey supplement
did not reduce blood glucose in healthy controlled rats.92 It is
thus asserted that honey may be a useful adjunct in the
management of diabetes, while serving as a sweetener,
especially if taken in moderate quantities.92
A recent clinical trial reported on a volunteer patient with
coronary heart disease (CHD), hypertension and type 2
diabetes mellitus who stopped all conventional medications
and used honey as an alternative therapy for almost 11 years.
In spite of persistent hyperglycaemia and dyslipidaemia, his
blood pressure was unexpectedly controlled, his CHD
improved or at least stabilized, and he did not develop ce-
rebral strokes. Moreover, he did not develop diabetic
ketoacidosis or a hyper-osmolar coma. However, he devel-
oped micro-vascular complications in the form of peripheral
neuritis and non-proliferative retinopathy after 6 and 8
years, respectively.93 The potential benefit of honey in type 2
diabetes mellitus has been extensively reviewed.94 Previously,
a study showed that honey intake considerably decreased the
postprandial glycaemic response or had a less adverse effect
on plasma glucose than other sugars or sweeteners in diabetic
patients. However, a contradictory report based on 8-week
consumption of natural honey led to a significant elevation
in glycosylated haemoglobin (HbA1C) levels, with no sig-
nificant change in fasting blood sugar (FBS) concentrations
in diabetic patients.95 Similarly, Omotayo et al.96 showed an
increase in serum antioxidant capacity with honey
consumption. Because oxidative stress has been implicated
both in the development of diabetes as well as its
complications, the novel antioxidant efficacy of honey
compounds might also afford an organ-protective effect,
which could limit the progression of diabetes and reduce
complications. It has been proposed that fructose and oli-
gosaccharides might contribute to the anti-diabetic effect of
honey.97,98 Research has demonstrated that fructose exerts a
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This synergistic effect might enhance intestinal fructose
absorption and stimulate insulin secretion. Thus, it may
enhance hepatic glucose uptake and glycogen synthesis and
storage via activation of hepatic glucokinase and glycogen
synthase, respectively.98 A study found that fructose-fed
rats had increased plasma insulin levels, and supplementa-
tion with oligofructose restored plasma insulin levels to those
of controls.99 In streptozotocin-induced diabetic rats, oligo-
fructose increased portal and pancreatic insulin concentra-
tions.100 Similarly, type 2 diabetic subjects or individuals
with impaired glucose tolerance treated with arabinoxylan
had reduced insulin levels.101 A combination of
oligofructose and polydextrose was reported to increase
insulin and C-peptide levels in type 2 diabetic patients.102
Natural honey lowered plasma glucose, C-reactive protein,
homocysteine, and blood lipids in healthy, diabetic, and
hyperlipidaemic subjects. The research reported that, in
diabetic patients, honey caused a significantly lower rise of
plasma glucose levels compared with dextrose.103
Dates (Phoenix dactylifera)
Date palm is one of the oldest cultivated plant known to
mankind. Dates are mentioned in the Holy Quran: Allah the
almighty says: “And from the fruits of date palms and
grapes, you derive strong drink and a goodly provision.
Verily, therein is indeed a sign for people who have wis-
dom.”58 It has been reported that the Prophet Muhammed
(peace be upon him) has elaborated on the medicinal
important of dates in curing several disorders, and he
suggested that Muslims eat date palm.104,105 S’ad bin Abi
Waqas, may Allah be pleased with him, narrated that the
Messenger of Allah, peace be upon him, said, “He who
eats seven dates of Madina (Ajwa dates) every morning
will not be affected by poison and magic on the day he eats
them.”14
The exact mode of action of dates in the control of dia-
betes is poorly understood and still under the scope of
research. Due to its reported antioxidant activities,106,107 one
could attribute such efficacy to enhanced insulin secretion
and inhibited absorption of glucose. Various active
compounds (flavenoids, steroids, phenol and saponines)
present in the extract of P. dactylifera were shown to play
an anti-diabetic role and scavenge free radicals liberated by
alloxan in diabetic rats.104 Recently, a diosmetin isolated
from an epicarp of date palm fruits was illustrated to play
a significant role in the improvement of different
biochemical results in diabetic rats.108
In a previous study, Mard et al.109 evaluated the anti-
diabetic and anti-lipidaemic activities of the hydroalcoholic
extract of P. dactylifera palm leaves and its fractions in
alloxan-induced diabetic rats. In their study, the researchers
demonstrated that oral administration of the extract and its
fractions improved body weight via decreased water intake
and caused hypoglycaemia in alloxan-induced diabetic
rats.109 A previous study opined that date palm consumption
could ameliorate hyperglycaemia and hyperlipidaemia in
diabetic patients.110 Results of this study demonstrate
significant anti-hyperglycaemic and anti-lipaemic effects.
Additionally, the mechanism of date palm hypoglycaemicactivity was demonstrated to be similar to that of hypo-
glycaemic sulphonylureas.111
A recent study used a multi-model analysis to evaluate the
efficacy of date palm fruit aqueous extract on streptozotocin-
induced diabetic rats.112 The study demonstrated that P.
dactylifera has the potential to prevent diabetes hazards
and can potentially improve diabetic neuropathy.112
Barley (Hordeum Vulgare)
Barley has been an important foodstuff in the Arabian
Peninsula since ancient times. It is reported that Aisha, may
Allah be pleased with her, used to recommend Talbina (a
meal made from powdered barley) for the sick or for those
grieving a deceased person. She (Aisha), may Allah be
pleased with her, said, “I heard the Messenger saying, ‘The
Talbina gives rest to the heart of the patient and makes it
active and relieves some of his sorrow and grief’.”82
Non-starch polysaccharides, resistant oligosaccharides,
lignin, and lignin complexes in plants, including other
analogous-carbohydrates, such as resistant starch, dextrins,
and synthesized carbohydrate compounds, such as poly-
dextrose, are categorized as dietary fibre.113 These kinds of
dietary fibres are mostly concentrated in cereals, fruits, and
vegetables. Research has demonstrated that daily dietary
fibre intake helps prevent many nutritional disorders,
including cardiovascular diseases, type 2 diabetes and
obesity.114,115
Barley is rich in fibre, particularly the soluble fibres b-
glucans (a viscous polysaccharide consisting of several D-
glucose units) and pectin.113 Clinical studies with diets
containing foods enriched in barley b-glucans revealed a
reduction of the glycaemic index (GI) and insulinaemic
response (GII).116 The high viscosity of barley’s b-glucans
in the gastrointestinal track incur a reduction of starch
digestion by a-amylase, and this is suspected to be the
likely mechanism by which b-glucans decrease the
postprandial glucose response.113,117 Furthermore, the
health benefits of b-glucans, such as reducing blood serum
cholesterol and regulating blood glucose levels, were shown
to be correlated with the amount and molecular weight of
the solubilized b-glucans in the gastrointestinal tract.117
The effect of barley consumption on the livers of diabetic
rat was investigated,118 and the study demonstrated the
amelioration of liver cells by barley consumption.
Dou et al.119 evaluated for the first time the relationship
between anti-diabetic activity and molecular conformation
of barley starch during the germination process. The research
employed the ability of asymmetrical flow field-flow frac-
tionation (AF4) coupled online with multi-angle light scat-
tering (MALS) and refractive index detectors (RI) for
monitoring changes in molecular conformation. The study
revealed that the ratio of the starch molecular radius of gy-
ration to the hydrodynamic radius and the apparent density
are among the primary parameters for the anti-diabetic effect
of barley’s starch.119 The results showed that, when
germinated, the apparent density and the anti-diabetic ac-
tivity of barley were significantly increased, suggesting that
germination makes the molecules more compact; this could
contribute to the enhancement of their anti-diabetic activity
(Figure 3).119
Figure 3: Variations of rat a-glucosidase inhibition with germi-
nation time for three different samples. Adopted from Dou
et al.119
B.Y. Sheikh346Zamzam water
Alkaline water is known to display strong antioxidant
activity that enhances its biological activity. Zamzam water
is a natural alkaline water that has also displayed the same
antioxidant activity as other alkaline waters.120 It is therefore
not surprising that its medicinal significance was highlighted
in the prophetic tradition. The Prophet, peace be upon him,
said: “The best water on the face of the earth is the water of
Zamzam; it is a kind of food and a healing from sickness.”121
Ibn Abbas, may Allah be pleased with him, narrated that The
Prophet, peace be upon him, said: “The water of Zamzam is
for whatever it is drunk for.”122
Zamzam water has been reported to increase total anti-
oxidants in rats with gentamycin-induced stress123 and to
possess oncolytic activity.124 It was also shown to cause
downregulation of genes that affect growth, integrin,
insulin-like growth factor and nuclear factor kappa beta,
and interleukins.125 It has been found that HbA1c is
negatively and significantly correlated with reduced
glutathione in diabetic patients.126 Recently, zamzam water
was shown to ameliorate oxidative stress and reduce HbA1c
in type 2 diabetic patients. The study reports that zamzam
group patients showed a significant increase in serum levels
of total antioxidants, catalase, superoxide dismutase, and
glutathione. Furthermore, patients who received zamzam
water had a significant decrease in HbA1c.126
Vinegar
Vinegar is a liquid produced via carbohydrate fermenta-
tion. Typically, it contains acetic acid at a concentration of
4e8%.127 The significance of vinegar in Islamic medicine was
established according to Aisha, may Allah be pleased with
her, who narrated that The Prophet, peace be upon him,
said: “The best of condiments is vinegar.”82 Naturally, it
also contains small amounts of vitamins, mineral salts,amino acids, polyphenolic compounds and non-volatile
organic acids.127 Although vinegar is mainly used as a
cooking ingredient, it has long been used in many ailments,
with claims of antiseptic, cardiovascular-protective, anti-
tumour and blood glucose-lowering effects.127 The earliest
known use of vinegar dates to more than a millennium
ago, and flavoured vinegar has been produced and sold as
a commercial product for five millennia.128 Recent studies
in both animal and human subjects have shown that
vinegar possesses hypoglycaemic activity.129,130
In rats, the effect of apple vinegar on serum glucose has
been investigated, and it has been reported that administra-
tion of apple vinegar results in a significant reduction in
serum glucose of diabetic animals (8.3  0.75 mmol/L) in
comparison with the control group (24.6  8.45 mmol/L).131
The study further iterated that the mode of action could be
mediated through enhanced secretion of insulin from the b-
cells of Langerhans or through an extrapancreatic
mechanism.131 Similar studies have attributed the
hypoglycaemic activity of vinegar to the presence of acetic
acid, which could prevent the complete digestion of
complex carbohydrates132 by either accelerating gastric
emptying or increasing the uptake of glucose by tissues,
thus lowering serum glucose.133 In humans, vinegar was
found to improve insulin sensitivity to a high carbohydrate
meal in subjects with insulin resistance or type 2
diabetes.134 The beneficial effect of vinegar in
streptozotocin-induced diabetic rats was evaluated.127 After
a month of administration, the researchers assayed the
fasting serum insulin concentrations by ELISA and the
pancreatic b and a-cell proportions using
immunofluorescence microscopy. Periodic acid Schiff
staining was performed to access glycogen contents and
histological changes in liver tissues. Compared with control
animals, the vinegar-treated rats were found to exhibit
weight loss, lower fasting and random blood glucose, higher
fasting serum insulin and higher b-cell proportions.127
Costus
Umm Qais, may Allah be pleased with her, narrated: I
went to The Prophet, peace be upon him, along with a son
of mine whose palate and tonsils I had pressed with my
finger as a treatment for a (throat and tonsil) disease. The
Prophet, peace be upon him, said, “Why do you pain your
children by pressing their throats! Use Oud Al-Hindi (In-
dian aloe wood, costus) for it cures seven diseases, one of
which is pleurisy.”14
According to contemporary medicine, costus, commonly
known as ‘insulin plant,’ is a member of the Zingiberacea
family and is used as a munching dietary supplement for the
treatment of diabetes in many parts of the world.135 Eliza
et al.136 evaluated the anti-diabetic and anti-lipidaemic ac-
tivity of eremanthin from Costus speciosus in streptozotocin-
induced diabetic rats. In this study, the isolated eremanthin
was administered to streptozotocin-induced diabetic male
Wistar rats at different doses (5, 10, 20 mg/kg bw) for 60
days. They reported that the treatment significantly reduced
plasma glucose levels in a dose-dependent manner when
compared to the controls. In addition, oral administration of
eremanthin (20 mg/kg bw) significantly decreased
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triglyceride, LDL-cholesterol and markedly increased
plasma insulin, tissue glycogen, HDL-cholesterol and serum
protein. Eremanthin also restored the altered plasma enzyme
(aspartate aminotransferase, alanine aminotransferase,
lactate dehydrogenase, alkaline phosphatase and acid phos-
phatase) levels to near normal.136 In a similar study, the
hypoglycaemic efficacy of Chrysolophus pictus leaf extract
was evaluated in normal as well as in streptozotocin-
induced diabetic rats.135 Orogastric intubation of the
aqueous leaf solution of this plant in diabetic rats for 28
days at a dosage of 2 mg/kg body weight exhibited a
significant reduction in fasting blood glucose levels and a
remarkable increase in serum insulin levels. It further
incurred significant reductions in serum parameters, such
as SGOT, SGPT, lipids, triglycerides, total cholesterol,
urea, TBARS, and albumin, in diabetic rats treated with
leaf solution. Additionally, the body weight of diabetic rats
was restored to normal when treated with the extract.
Morphometric analysis of extract-treated pancreatic islets
showed a significant increase in the number and area of islets
when compared with normal and diabetic control rats.135
Previously, Jayasri et al.137 evaluated C. pictus extract for
its ability to inhibit a-amylase and a-glucosidase as an
alternative management of diabetes. In vitro assays
revealed that methanol, aqueous, ethyl acetate and
ethanolic extracts of C. pictus had good inhibitory effects
on carbohydrate hydrolysing enzymes, such as like a-
glucosidase and a-amylase. The study illustrated that all
the tested extracts of C. pictus showed good inhibitory
activity, and higher a-amylase inhibitory effects were
shown by aqueous extracts of approximately 84.16% at a
concentration of 100 mg/ml. Similarly, the aqueous extract
also showed a higher inhibitory effect (79%) in an a-
glucosidase inhibitory assay.137 Similarly, anti-diabetic ac-
tivity of C. pictus on alloxan-induced diabetic rats has been
shown.138 As expected, the study also reported a significant
reduction in serum glucose levels and lipid profiles.138 The
anti-hyperglycaemic activity of various extracts of C. spe-
ciosus rhizomes in streptozotocin-induced diabetes139 and
alloxan-induced type 2 diabetes mellitus in albino rats140
has also been reported.Figure 4: Structures of vitexin (1) and isovitexin (2). Adopted
from Choo et al.146Truffle (Terfeziaceae)
Truffle is a fruiting body of a subterranean fungus, the
majority of which belongs to the genus Tuber. Mushrooms
are an important source of nutrients and physiologically
beneficial, non-toxic medicines.141 In fact, mushrooms have
been used in folk medicine throughout the world since
ancient times. The Prophet, peace be upon him, said: “The
kam’ah (truffle) is from al-Mann (which is a food
mentioned in the Quran, Surah al-Baqarah), and its water is
a cure for the eye.”14,82 Biochemical analyses have shown
mushrooms to contain large amounts of vitamin A, C and
b-carotene, all of which are known for their antioxidant
properties.141 Aldose reductase is a cytosolic NADPH-
dependent oxidoreductase enzyme that catalyses the reduc-
tion of glucose to sorbitol as the first step of the noxious
polyol pathway of glucose metabolism. Lee et al.142 isolated
eight biochemical compounds from the truffles ofGanoderma applanatum, and the isolated compounds were
found to exhibit inhibitory properties against aldose
reductase.142
Fig (Ficus carica)
F. carica L. belongs to the family Moraceae. It is such a
revered plant that Allah has sworn with it in the holy Quran:
“By the fig and the olive! And the mount of Sinai, and this
safe country (Makkah)! Indeed, we created the human with
the fairest stature.”58 Fig is grown in nearly all tropical and
sub-tropical countries.143 Aqueous extracts of F. carica
have hypoglycaemic activity in streptozotocin-induced dia-
betic rats.144 The study reported administering a decoction to
rats for three weeks. The extract was found to significantly
decrease plasma glucose levels in diabetic rats. Plasma
insulin levels were also significantly increased by treatment
of non-diabetic rats.144 The hypoglycaemic effect of fig
fruit and leaf extracts on alloxan-induced diabetic rats has
been reported.145 Vitexin and isovitexin (Figure 4) isolated
from Ficus deltoidea were shown to possess inhibitory
effects on a-glucosidase.146 Oral administration of 1 mg/kg
of either vitexin or isovitexin significantly reduced
postprandial blood glucose levels in sucrose loaded
normoglycaemic mice after 30 min. Khan et al.147 have
written a detailed review on the hypoglycaemic effect of the
genus Ficus spp.
Cucurbitaceae
The formal account of Cucurbitaceae in the Quran is
mentioned in Surah As-Saffat, 146. Allah the almighty
says: “And We caused a plant of gourd to grow over him.”
Unripe fruits, seeds and aerial parts of Momordica
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the treatment of several ailments. Oral administration of
fruit juice or seed powder causes a reduction in fasting
blood glucose and improves glucose tolerance in normal
and diabetic animals and in humans.148 Previously,
Higashino et al.149 found that a polar solvent extract of
M. charantia improved tolerance to both orally and
intraperitoneally administered glucose, suggesting the
involvement of impaired glucose absorption from the
gastrointestinal tract. Bio-guided fractionation of the
methanol extract of M. charantia dried gourds led to the
isolation of three new cucurbitane triterpenoids with
hypoglycaemic activity.150 Previous research has reported
the hypoglycaemic activity Cucurbita ficifolia fruit
extract on streptozotocin-induced diabetic rats.151 It has
been described that feeding diabetic rats with C. ficifolia
fruit extract causes a reduction in STZ-induced hyper-
glycaemia, increased plasma insulin levels, and markedly
reduced STZ-induced lipid peroxidation in the pancreas.
Further, there was a significant increase in the number of
b-cells in C. ficifolia-treated animals when compared with
untreated diabetic rats.151 The anti-diabetic activity of
protein globulins obtained from several of the selected five
species of Cucurbitaceae seeds has been reported.152 An
oral glucose tolerance test showed that the globulins of
the seeds of all species except Cucumeropsis mannii
caused a significant drop in blood sugar compared to the
controls.152 Similar reductions in blood glucose levels
were observed with Coccinia indica extract.153
Conclusions
Considerable evidence from experimental studies has
demonstrated that the above mentioned therapeutic items of
prophetic medicine may provide benefits in the management
of diabetes mellitus. These potential benefits could be both in
terms of better control of the hyperglycaemic state as well as
interactions with metabolic pathways and a reduction of
noxious effects on organs that produce diabetic complica-
tions. However, most of the studies on experimental animal
models of diabetes have employed synthetic drug (streptozo-
tocin or alloxan)-induced diabetes, whichmaynot truly reflect
the development of diabetes in humans, especially type 2. It is
therefore necessary that studies are carried out in other animal
models, such as high-fat diet fed obese animals or genetically
prone animals, which might correlate more closely with hu-
man type 2 diabetes.Moreover, the promising bioactivity seen
in experimental studies needs to be further investigated in
well-designed, controlled clinical trials to determine whether
these can be duplicated in clinical scenarios.
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